Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00737646 · ClinicalTrials.gov registry record · NA

Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics

A NA study of Colorectal Cancer, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
NA
Development phase
5,066
Enrollment target
3
Study locations

NCT00737646: Completed NA study of Colorectal Cancer, sponsored by Centers for Disease Control and Prevention.

NCT00737646 is a NA study of Colorectal Cancer that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 5,066 participants, above the 1,531-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (231% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00737646, a NA study of Colorectal Cancer, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
NA
Development phase
5,066 participants
Enrollment target
3
Study locations

Study Summary

This study is a three-arm randomized controlled trial to implement and evaluate the relative effects of: 1) clinic-focused intervention; 2) combined patient- and clinic-focused intervention, and 3) usual care on the provision of colorectal cancer (CRC) screening in primary care clinics. The study will also examine the relative effects of the intervention conditions on secondary behavioral outcomes (e.g., clinician-patient discussions about CRC screening) and on intermediate outcome measures of attitudes, beliefs, opinions, and social influence surrounding CRC screening among patients, clinicians, and clinical staff. The target population includes average-risk patients aged 50-75 years, clinicians, and clinical staff within the primary care setting. The intervention will be implemented within primary care clinics in two managed care organizations (MCOs). The intervention targets the following CRC screening modalities: fecal occult blood test (FOBT), flexible sigmoidoscopy, colonoscopy, and double contrast barium enema.

Conditions Studied

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL Clinic-focused intervention
  • BEHAVIORAL Clinic- and patient-focused

Study Locations (3)

Michigan

  • Henry Ford Health System - Detroit

New Mexico

  • ABQ Health Partners/Lovelace Clinic Foundation - Albuquerque

Washington

  • Battelle Centers for Public Health Research and Evaluation - Seattle

Trial Details

FieldValue
Enrollment Target 5,066 participants
Start Date 2009-07
Est. Completion 2011-12
Phase NA

What the finished NCT00737646 record still lists

NCT00737646 is an interventional study that assigns participants to a tested intervention. Its 5,066 participants enrollment target places it among the larger protocols in the corpus, above the 1,531-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (231% higher).

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 3 interventions - of which Usual care is the first listed.

NCT00737646 reports a single indexed study location in Michigan, New Mexico, Washington.

Frequently Asked Questions

What is clinical trial NCT00737646 about?

NCT00737646 is a clinical study titled "Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics". This study is a three-arm randomized controlled trial to implement and evaluate the relative effects of: 1) clinic-focused intervention; 2) combined patient- and clinic-focused intervention, and 3) usual care on the provision of colorectal cancer (CRC) screening in primary care clinics. The study wi...

What is the current status of trial NCT00737646?

This trial is currently completed. It is a NA study. The enrollment target is 5,066 participants. The study started on 2009-07. Estimated completion is 2011-12.

What conditions does trial NCT00737646 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT00737646?

The interventions under investigation include: Usual care (BEHAVIORAL), Clinic-focused intervention (BEHAVIORAL), Clinic- and patient-focused (BEHAVIORAL).

Who is sponsoring clinical trial NCT00737646?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00737646 being conducted?

This trial has 3 study locations across Michigan, New Mexico, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00737646's enrollment target sits among peer trials

5,066 17th of 381 higher than 365 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06292078 · 5,076 participants · NA

    Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

  • NCT07037459 · 5,056 participants · Phase 3

    Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • NCT05018611 · 5,100 participants · NA

    Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

  • NCT05701358 · 5,100 participants · NA

    Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00737646, the US trial registry maintained by the National Library of Medicine. NCT00737646 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.